1. Home
  2. HDSN vs RLMD Comparison

HDSN vs RLMD Comparison

Compare HDSN & RLMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hudson Technologies Inc.

HDSN

Hudson Technologies Inc.

HOLD

Current Price

$7.23

Market Cap

318.2M

ML Signal

HOLD

Logo Relmada Therapeutics Inc.

RLMD

Relmada Therapeutics Inc.

HOLD

Current Price

$4.08

Market Cap

319.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HDSN
RLMD
Founded
1991
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
318.2M
319.7M
IPO Year
1996
2012

Fundamental Metrics

Financial Performance
Metric
HDSN
RLMD
Price
$7.23
$4.08
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
3
Target Price
$9.50
$9.00
AVG Volume (30 Days)
195.4K
620.1K
Earning Date
01-01-0001
03-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
19.21
EPS
0.56
N/A
Revenue
$237,118,000.00
$13,070.00
Revenue This Year
$3.38
N/A
Revenue Next Year
$2.96
N/A
P/E Ratio
$13.18
N/A
Revenue Growth
N/A
154.83
52 Week Low
$5.11
$0.24
52 Week High
$10.52
$5.12

Technical Indicators

Market Signals
Indicator
HDSN
RLMD
Relative Strength Index (RSI) 47.81 52.37
Support Level $6.93 $3.81
Resistance Level $7.65 $4.56
Average True Range (ATR) 0.26 0.35
MACD -0.01 0.04
Stochastic Oscillator 32.35 69.19

Price Performance

Historical Comparison
HDSN
RLMD

About HDSN Hudson Technologies Inc.

Hudson Technologies Inc is an American industrial products manufacturer. It develops products which are mainly used in commercial air conditioning, industrial processing, and refrigeration systems. The company products include refrigerant and industrial gases, refrigerant management services and RefrigerantSide services, which consist of system decontamination. These are performed at customer's site using its Zugibeast system, which is a fast and portable system and allows the R-Side services team to accelerate critical services while saving customers time, money and aggravation. The company also owns a web-based real-time monitoring service which is used in the facility's refrigeration systems and other energy systems.

About RLMD Relmada Therapeutics Inc.

Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its key product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.

Share on Social Networks: